PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Feb-2024 IMODIUM® launches new Gut2KnowTM app: diarrhoea sufferers can now boost their gut health with personalised data Imodium
01-Feb-2024 Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation Businesswire
01-Feb-2024 NICE Recommends Subcutaneous Treatment Option Tepkinly® ▼ (epcoritamab) for Eligible* Adults with Aggressive Form of Blood Cancer After Two or More Lines of Systemic Therapy AbbVie UK
01-Feb-2024 New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO) Businesswire
01-Feb-2024 Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products Businesswire
01-Feb-2024 L&T Technology Services supports Marelli in Revolutionizing Automotive Infotainment with Digital Twin Technology Businesswire
01-Feb-2024 Bedless Hospitals Market Charts a Remarkable Ten-Year Projection of Value from 2023 to 2033 MARKITWIRED
01-Feb-2024 DOUGLAS updates sustainability strategy with ambitious goals Douglas GmbH
01-Feb-2024 3D Imaging Surgical Solutions Market Envisioning a Future Valued at US$ 263.9 Million by 2033 MARKITWIRED
01-Feb-2024 Veterinary Antibiotic Market Primed to Soar Past US$ 20,154.0 Million by 2033 MARKITWIRED
01-Feb-2024 3D-Printed Maxillofacial Implants Market Aims to Surpass US$ 1,119.1 Million by 2033 MARKITWIRED
01-Feb-2024 Vaginal Specula Market Gears Up for Explosive Growth, Projected to Exceed US$ 1,301.5 Million by 2033 MARKITWIRED
01-Feb-2024 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference AccessWire
01-Feb-2024 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference Kuros Biosciences AG
31-Jan-2024 Moderna Named to Fortune's List of World's Most Admired Companies AccessWire
31-Jan-2024 Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset AccessWire
31-Jan-2024 AltaThera Pharmaceuticals at AF Symposium 2024 AccessWire
31-Jan-2024 AltaThera Pharmaceuticals at AF Symposium 2024 Newswire
31-Jan-2024 Vita 34 publishes preliminary figures on the course of business in 2023 Vita 34 AG
31-Jan-2024 ALMOST HALF OF PATIENTS REMAIN UNAWARE OF THE GOVERNMENT’S PHARMACY FIRST SERVICE Charac